Viewbix Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Viewbix Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $26.94M | Mar 21, 2025 |
| FY2023 | Dec 31, 2023 | $79.61M | Mar 25, 2024 |
| FY2023 | Dec 31, 2022 | $96.60M | Mar 25, 2024 |
| FY2015 | Dec 31, 2015 | $0 | Mar 31, 2016 |
| FY2015 | Dec 31, 2014 | $0 | Mar 31, 2016 |
| FY2014 | Dec 31, 2013 | $0 | Mar 12, 2015 |
| FY2013 | Dec 31, 2012 | $0 | Mar 24, 2014 |
| FY2012 | Dec 31, 2011 | $0 | Mar 29, 2013 |
| FY2011 | Dec 31, 2010 | $0 | Mar 19, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $26.94M | Mar 21, 2025 |
| FY2024 | Dec 31, 2023 | $79.61M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $96.60M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $45.22M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $96.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $208.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $252.0K | Mar 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $41.0K | Mar 17, 2022 |
| FY2021 | Dec 31, 2020 | $91.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $206.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $177.0K | Mar 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.29M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($12.05M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($7.32M) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $28.0K | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $300.0K | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($443.0K) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($1.12M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($575.0K) | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($1.53M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($6.15M) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.18M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($837.0K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($7.47M) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.73M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $541.0K | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($454.0K) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($1.00M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($578.0K) | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($557.3K) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($5.39M) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $830.0K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.89M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.26M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $2.37M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $108.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $233.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $258.0K | Mar 20, 2020 |
| FY2017 | Dec 31, 2017 | ($354.8K) | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | ($1.64M) | Apr 17, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.54M | Mar 21, 2025 |
| FY2024 | Dec 31, 2023 | $934.0K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.24M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $4.37M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($53.0K) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($135.0K) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $30.0K | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($630.0K) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($858.5K) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($1.30M) | Apr 18, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.0K | Mar 21, 2025 |
| FY2024 | Dec 31, 2023 | $16.0K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $58.0K | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $311.0K | Mar 24, 2023 |
| FY2020 | Dec 31, 2019 | $2.0K | Mar 16, 2021 |
| FY2017 | Dec 31, 2016 | $23.1K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $26.2K | Apr 18, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.76M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $21.97M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $43.28M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $63.70M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $51.26M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $225.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $230.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $158.0K | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $29.5K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $57.6K | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $975.2K | Mar 29, 2019 |
| FY2018 | Dec 31, 2017 | $1.62M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $1.29M | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $288.8K | Apr 18, 2017 |
| FY2015 | Dec 30, 2015 | $288.8K | Mar 31, 2016 |
| FY2015 | Dec 31, 2014 | $137.6K | Mar 31, 2016 |
| FY2014 | Dec 31, 2013 | $278.8K | Mar 12, 2015 |
| FY2013 | Dec 31, 2012 | $227.4K | Mar 24, 2014 |
| FY2012 | Dec 31, 2011 | $176.7K | Mar 29, 2013 |
| FY2011 | Dec 31, 2010 | $143.8K | Mar 19, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.99M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.77M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $14.82M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $22.02M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $13.71M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($2.08M) | Mar 17, 2022 |
| FY2021 | Dec 31, 2019 | ($1.69M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2018 | ($721.0K) | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | ($395.0K) | Mar 20, 2020 |
| FY2018 | Dec 31, 2016 | ($1.24M) | Mar 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.39M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.08M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $12.25M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $17.36M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $12.48M | Mar 24, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($46.05M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($22.71M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($10.66M) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | ($3.34M) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | ($2.37M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($15.15M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($14.71M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($13.59M) | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($16.62M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($15.05M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $24.0K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.77M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $4.20M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $5.21M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $148.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $87.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $51.0K | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $3.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $4.5K | Apr 17, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.49M | Mar 27, 2026 |
| FY2024 | Dec 31, 2024 | $6.65M | Mar 21, 2025 |
| FY2023 | Dec 31, 2023 | $9.50M | Mar 25, 2024 |
| FY2022 | Dec 31, 2022 | $9.45M | Mar 24, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 24, 2023 |
| FY2014 | Dec 31, 2014 | 0 | Mar 12, 2015 |
| FY2014 | Dec 31, 2013 | 0 | Mar 12, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10.67M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 5.30M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 3.73M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 14.78M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 14.78M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 34.75M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 31.20M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 273,049 | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | 22.54M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 19.96M | Apr 17, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $130.0K | Mar 21, 2025 |